150 related articles for article (PubMed ID: 28055240)
1. Multimodality Technologies in the Assessment of Hematolymphoid Neoplasms.
Li S; Jaye DL; Bradley KT; Zhang L; Saxe D; Deeb G; Hill CE; Mann KP
Arch Pathol Lab Med; 2017 Mar; 141(3):341-354. PubMed ID: 28055240
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometry immunophenotyping of hematolymphoid neoplasia.
Calvo KR; McCoy CS; Stetler-Stevenson M
Methods Mol Biol; 2011; 699():295-316. PubMed ID: 21116989
[TBL] [Abstract][Full Text] [Related]
3. [Essentials of conventional and molecular cytogenetics: application to diagnosis of hematological malignancies].
Lafage-Pochitaloff M
Pathol Biol (Paris); 2003 Aug; 51(6):307-11. PubMed ID: 12927887
[No Abstract] [Full Text] [Related]
4. Flow cytometric immunophenotyping for hematologic neoplasms.
Craig FE; Foon KA
Blood; 2008 Apr; 111(8):3941-67. PubMed ID: 18198345
[TBL] [Abstract][Full Text] [Related]
5. The use of new technologies in the detection of balanced translocations in hematologic disorders.
Shaffer LG; Schultz RA; Ballif BC
Curr Opin Genet Dev; 2012 Jun; 22(3):264-71. PubMed ID: 22336526
[TBL] [Abstract][Full Text] [Related]
6. Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification.
Martín-Subero JI; Gesk S; Harder L; Grote W; Siebert R
Anticancer Res; 2003; 23(2A):1139-48. PubMed ID: 12820362
[TBL] [Abstract][Full Text] [Related]
7. 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications.
Davis BH; Holden JT; Bene MC; Borowitz MJ; Braylan RC; Cornfield D; Gorczyca W; Lee R; Maiese R; Orfao A; Wells D; Wood BL; Stetler-Stevenson M
Cytometry B Clin Cytom; 2007; 72 Suppl 1():S5-13. PubMed ID: 17803188
[TBL] [Abstract][Full Text] [Related]
8. [Emerging Technologies Support the Molecular Basis of the WHO Classification of Hematopoietic Neoplasms].
Miyachi H
Rinsho Byori; 2014 Nov; 62(11):1056-64. PubMed ID: 27509721
[TBL] [Abstract][Full Text] [Related]
9. Towards a molecular classification of hematolymphoid neoplasms: where are we now? Where are we going?
Hsi ED
J Histochem Cytochem; 2001 Oct; 49(10):1323-4. PubMed ID: 11561018
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnosis of hematopoietic and lymphoid neoplasms.
Jevremovic D; Viswanatha DS
Hematol Oncol Clin North Am; 2009 Aug; 23(4):903-33. PubMed ID: 19577174
[TBL] [Abstract][Full Text] [Related]
11. Role of flow cytometry in pediatric hematopathology.
Kroft SH
Am J Clin Pathol; 2004 Dec; 122 Suppl():S19-32. PubMed ID: 15690640
[TBL] [Abstract][Full Text] [Related]
12. [Introduction to the molecular diagnostic methods of oncohematology].
Király AP; Alpár D; Fésüs V; Marosvári D; Matolcsy A; Bödör C
Magy Onkol; 2016 Jun; 60(2):88-98. PubMed ID: 27275635
[TBL] [Abstract][Full Text] [Related]
13. Report of proceedings of the national meeting on "Guidelines for Immunophenotyping of Hematolymphoid Neoplasms by Flow Cytometry".
Gujral S; Subramanian PG; Patkar N; Badrinath Y; Kumar A; Tembhare P; Vazifdar A; Khodaiji S; Madkaikar M; Ghosh K; Yargop M; Dasgupta A
Indian J Pathol Microbiol; 2008; 51(2):161-6. PubMed ID: 18603672
[TBL] [Abstract][Full Text] [Related]
14. International consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia.
Wilson WH
Cytometry B Clin Cytom; 2007; 72 Suppl 1():S2. PubMed ID: 17803186
[No Abstract] [Full Text] [Related]
15. [Minimal residual disease in hematology].
Rák K
Orv Hetil; 2001 May; 142(21):1091-5. PubMed ID: 11449837
[No Abstract] [Full Text] [Related]
16. Frozen sections in hematopathology.
Solomon AC; Kossev PM
Semin Diagn Pathol; 2002 Nov; 19(4):255-62. PubMed ID: 12469792
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia: conventional cytogenetics, FISH, and moleculocentric methodologies.
Morrissette JJ; Bagg A
Clin Lab Med; 2011 Dec; 31(4):659-86, x. PubMed ID: 22118743
[TBL] [Abstract][Full Text] [Related]
18. [Flow cytometry: application for the diagnosis and the follow-up of hematological malignancies].
Drénou B; Fardel O; Fauchet R; Amiot L
Ann Biol Clin (Paris); 2002; 60(6):663-72. PubMed ID: 12446230
[TBL] [Abstract][Full Text] [Related]
19. Synoptic tool for reporting of hematological and lymphoid neoplasms based on World Health Organization classification and College of American Pathologists checklist.
Mohanty SK; Piccoli AL; Devine LJ; Patel AA; William GC; Winters SB; Becich MJ; Parwani AV
BMC Cancer; 2007 Jul; 7():144. PubMed ID: 17672904
[TBL] [Abstract][Full Text] [Related]
20. Intracytoplasmic antigen study by flow cytometry in hematolymphoid neoplasm.
Gujral S; Tembhare P; Badrinath Y; Subramanian PG; Kumar A; Sehgal K
Indian J Pathol Microbiol; 2009; 52(2):135-44. PubMed ID: 19332897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
